4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Medicus Pharma Ltd. (MDCX) operates in the Drug Manufacturers - General industry and is headquartered in West Conshohocken, United States with about 16 employees. Its market capitalization is roughly $21 million. In the fiscal year ended 2025-12-31, MDCX reported $0M in revenue and ($35M) in net income.
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($34M) | ($11M) | ($3M) | ($1M) | — |
| Net Income | ($35M) | ($11M) | ($5M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($9M) | ($8M) | ($15M) | ($6M) | ($5M) | — |
| Net Income | ($9M) | ($8M) | ($16M) | ($6M) | ($5M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $10M | $6M | $2M | $0M | — |
| Total Liabilities | $10M | $2M | $1M | $12M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MDCX viewer.
About TickerBase · Data methodology & sources